Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-23

Clinical Trial Update: Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed absorption and tolerability of intranasal ketorolac tromethamine and evaluated whether oxymetazoline hydrochloride or fluticasone pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (intranasal) (fluticasone propionate)
  • Ketorolac tromethamine intranasal (ketorolac tromethamine)
  • Oxymetazoline hydrochloride (intranasal) (oxymetazoline hydrochloride)

Snippet

Sponsor: Egalet Ltd | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED | Results posted: 2015-07-23